Identification of the novel HLA-A*01:01:01:111 allele in two individuals from Uttar Pradesh, India.

Humans Alleles India Histocompatibility Testing HLA-A Antigens / genetics High-Throughput Nucleotide Sequencing
genomic DNA next generation sequencing novel allele

Journal

HLA
ISSN: 2059-2310
Titre abrégé: HLA
Pays: England
ID NLM: 101675570

Informations de publication

Date de publication:
07 2023
Historique:
revised: 02 03 2023
received: 16 02 2023
accepted: 02 03 2023
medline: 15 6 2023
pubmed: 17 3 2023
entrez: 16 3 2023
Statut: ppublish

Résumé

The novel HLA-A*01:01:01:111 allele was detected during routine HLA typing.

Identifiants

DOI: 10.1111/tan.15021 PMID: 36924429
pubmed: 36924429
doi: 10.1111/tan.15021
doi:

Substances chimiques

HLA-A Antigens 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

65-66

Informations de copyright

© 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Barker DJ, Maccari G, Georgiou X, et al. IPD-IMGT/HLA Database. Nucleic Acids Res. 2023;51:D1053-D1060.
Marsh SG, Albert ED, Bodmer WF, et al. Nomenclature for factors of the HLA system, 2010. Tissue Antigens. 2010;75(4):291-455. doi:10.1111/j.1399-0039.2010.01466.x

Auteurs

Andrea S Pinto (AS)

Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Mumbai, India.
ORCID: 0000-0002-8831-1326

Jyoti Rajak (J)

Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Mumbai, India.
ORCID: 0000-0002-2618-2418

Manisha Tambe (M)

Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Mumbai, India.
ORCID: 0000-0002-3824-2174

Selma Z D'Silva (SZ)

Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Mumbai, India.
ORCID: 0000-0003-3864-5552

Meenakshi Singh (M)

Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Mumbai, India.
Homi Bhabha National Institute, Mumbai, India.
ORCID: 0000-0003-3898-4642

Articles similaires

Comprehensive comparative analysis and development of molecular markers for Lasianthus species based on complete chloroplast genome sequences.

Yue Zhang, Meifang Song, Deying Tang et al.
1.00
Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Identification of the novel HLA-A*01:01:01:111...
questionsmedicales.fr › Phénomènes génétiques › Structures génétiques › Génome › Composants de génome › Gènes › Allèles › Identification of the novel HLA-A*01:01:01:111...
questionsmedicales.fr › Régions géographiques › Asie › Asie de l'Ouest › Asie du Sud › Inde › Identification of the novel HLA-A*01:01:01:111...
questionsmedicales.fr › Techniques d'investigation › Techniques immunologiques › Tests immunologiques › Test d'histocompatibilité › Identification of the novel HLA-A*01:01:01:111...
questionsmedicales.fr › Facteurs biologiques › Antigènes › Isoantigènes › Antigènes d'histocompatibilité › Antigènes HLA › Antigènes HLA-A › Identification of the novel HLA-A*01:01:01:111...
questionsmedicales.fr › Techniques d'investigation › Techniques génétiques › Analyse de séquence › Séquençage nucléotidique à haut débit › Identification of the novel HLA-A*01:01:01:111...